Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00426127
Status:
TERMINATED
Last Update Posted:
2017-12-29
First Post:
2007-01-23
Brief Title:
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Sponsor:
University of Iowa
Organization:
University of Iowa
Organization Data
Organization:
University of Iowa
Class:
OTHER
Study ID:
200511721
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Iowa
Lead Sponsor Class:
OTHER
Responsible Party:
Daniel Berg
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Iowa
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |